This finding is in accordance with the enrichment of DLL1 in BCSCs [20] and the reduction of BCSC number and function in ER+ BC cells upon the loss of DLL1 [17] and Notch signaling blockade [46]. This evidence concerns the gene DLL1 and breast cancer.